Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2

MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures

Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,011 · see citing works

Protein modules and signalling networks

Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420 · see citing works

Signaling Through Scaffold, Anchoring, and Adaptor Proteins

Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256 · see citing works

Three-dimensional structure of the tyrosine kinase c-Src

Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,428 · see citing works

Crystal structure of the Src family tyrosine kinase Hck

Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,181 · see citing works

Crystal Structure of the Tyrosine Phosphatase SHP-2

Hof, P., Pluskey, S., Dhe‐Paganon, S., Eck, M. J., & Shoelson, S. E. (1998) · Cell · doi:10.1016/s0092-8674(00)80938-1 · Cited by 996 · see citing works

CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B

Barford, D., Flint, A. J., & Tonks, N. K. (1994) · Science · doi:10.1126/science.8128219 · Cited by 762 · see citing works

Protein tyrosine phosphatases in signal transduction

Neel, B. G., & Tonks, N. K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80063-4 · Cited by 757 · see citing works

Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement

Moarefi, I., LaFevre-Bernt, M. A., Sicheri, F., Huse, M., Lee, C., Kuriyan, J., & Miller, W. T. (1997) · Nature · doi:10.1038/385650a0 · Cited by 601 · see citing works

Structural Basis for Phosphotyrosine Peptide Recognition by Protein Tyrosine Phosphatase 1B

Jia, Z., Barford, D., Flint, A. J., & Tonks, N. K. (1995) · Science · doi:10.1126/science.7540771 · Cited by 583 · see citing works

MODULAR PEPTIDE RECOGNITION DOMAINS IN EUKARYOTIC SIGNALING

Kuriyan, J., & Cowburn, D. (1997) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.26.1.259 · Cited by 549 · see citing works

Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp‐2

Saxton, T. M., Henkemeyer, M. J., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G., & Pawson, T. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2352 · Cited by 481 · see citing works

corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso

Perkins, L. A., Larsen, I., & Perrimon, N. (1992) · Cell · doi:10.1016/0092-8674(92)90098-w · Cited by 402 · see citing works

Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate

Stuckey, J. A., Schubert, H., Fauman, E. B., Zhang, Z., Dixon, J. E., & Saper, M. A. (1994) · Nature · doi:10.1038/370571a0 · Cited by 391 · see citing works

The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early xenopus development

Tang, T. L., Freeman, R. M., O’Reilly, A. M., Neel, B. G., & Sokol, S. Y. (1995) · Cell · doi:10.1016/0092-8674(95)90498-0 · Cited by 324 · see citing works

Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization

Bilwes, A. M., den Hertog, J., Hunter, T. R., & Noel, J. P. (1996) · Nature · doi:10.1038/382555a0 · Cited by 324 · see citing works

Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.

Lechleider, R. J., Sugimoto, S., Bennett, A. M., Kashishian, A., Cooper, J. A., Shoelson, S. E., Walsh, C. T., & Neel, B. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80562-6 · Cited by 319 · see citing works

Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains

Pluskey, S., Wandless, T. J., Walsh, C. T., & Shoelson, S. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.2897 · Cited by 285 · see citing works

Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase

Desai, D. M., Sap, J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90141-c · Cited by 280 · see citing works

Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography

Pannifer, A., Flint, A. J., Tonks, N. K., & Barford, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10454 · Cited by 237 · see citing works

Tandem SH2 Domains Confer High Specificity in Tyrosine Kinase Signaling

Ottinger, E. A., Botfield, M. C., & Shoelson, S. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.729 · Cited by 237 · see citing works

Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1.

Sugimoto, S., Wandless, T. J., Shoelson, S. E., Neel, B. G., & Walsh, C. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36874-6 · Cited by 213 · see citing works

Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase

Lee, C., Kominos, D., Jacques, S. L., Margolis, B. L., Schlessinger, J., Shoelson, S. E., & Kuriyan, J. (1994) · Structure · doi:10.1016/s0969-2126(00)00044-7 · Cited by 205 · see citing works

Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2

Eck, M. J., Pluskey, S., Trüb, T., Harrison, S. C., & Shoelson, S. E. (1996) · Nature · doi:10.1038/379277a0 · Cited by 199 · see citing works

Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue, SH-PTP2

Lechleider, R. J., Freeman, R. M., & Neel, B. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38668-5 · Cited by 191 · see citing works

Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.

Pei, D., Wang, J.-F., & Walsh, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1141 · Cited by 143 · see citing works

Structural Determinants of SHP-2 Function and Specificity in Xenopus Mesoderm Induction

O’Reilly, A. M., & Neel, B. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.161 · Cited by 116 · see citing works

The Nonreceptor Protein Tyrosine Phosphatase Corkscrew Functions in Multiple Receptor Tyrosine Kinase Pathways inDrosophila

Perkins, L. A., Johnson, M. R., Melnick, M. B., & Perrimon, N. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0285 · Cited by 114 · see citing works

The Crystal Structure of Domain 1 of Receptor Protein-tyrosine Phosphatase μ

Hoffmann, K. M. V., Tonks, N. K., & Barford, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27505 · Cited by 112 · see citing works

The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf

Allard, J. D., Chang, H. C., Herbst, R., McNeill, H., & Simon, M. A. (1996) · Development · doi:10.1242/dev.122.4.1137 · Cited by 104 · see citing works

Characterization of protein tyrosine phosphatase SH-PTP2. Study of phosphopeptide substrates and possible regulatory role of SH2 domains.

Dechert, U., Adam, M., Harder, K. W., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37504-x · Cited by 94 · see citing works

Overexpression, purification, and characterization of SHPTP1, a Src homology 2-containing protein-tyrosine-phosphatase.

Pei, D., Neel, B. G., & Walsh, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1092 · Cited by 60 · see citing works

Regulation of protein tyrosine phosphatase 1C: opposing effects of the two src homology 2 domains

Pregel, M. J., Shen, S., & Storer, A. C. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.12.1309 · Cited by 18 · see citing works

The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · see citing works

PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ

Sheppard, K.-A., Fitz, L. J., Lee, J. M., Benander, C., George, J. A., Wooters, J., Qiu, Y., Jussif, J. M., Carter, L. L., Wood, C. R., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.083 · Cited by 791 · see citing works

Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia

Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop

Rolli, V., Gallwitz, M., Wossning, T., Flemming, A., Schamel, W. W. A., Zürn, C., & Reth, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00739-6 · Cited by 331 · see citing works

Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor

Garcia Fortanet, J., Chen, C. H.-T., Chen, Y.-N. P., Chen, Z., Deng, Z., Firestone, B., Fekkes, P., Fodor, M., Fortin, P. D., Fridrich, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00680 · Cited by 298 · see citing works

The Tyrosine Phosphatase Shp2 in Development and Cancer

(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)06002-1 · Cited by 277 · see citing works

SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling

Fedele, C., Li, S., Teng, K. W., Foster, C. J. R., Peng, D., Ran, H., Mita, P., Geer, M. J., Hattori, T., Koide, A., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201414 · Cited by 265 · see citing works

Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors

Araki, T., Nawa, H., & Neel, B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306461200 · Cited by 231 · see citing works

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

LaMarche, M. J., Acker, M., Argintaru, A., Bauer, D., Boisclair, J., Chan, H., Chen, C. H.-T., Chen, Y.-N., Chen, Z., Deng, Z., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01170 · Cited by 231 · see citing works

The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling

Kolli, S., Zito, C. I., Mossink, M. H., Wiemer, E. A. C., & Bennett, A. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313955200 · Cited by 154 · see citing works

Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2

Pádua, R. A. P., Sun, Y., Marko, I., Pitsawong, W., Stiller, J. B., Otten, R., & Kern, D. (2018) · Nature Communications · doi:10.1038/s41467-018-06814-w · Cited by 133 · see citing works

Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment

Kerr, D. L., Haderk, F., & Bivona, T. G. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.11.007 · Cited by 124 · see citing works

A comprehensive review of SHP2 and its role in cancer

Asmamaw, M. D., Shi, X.-J., Zhang, L.-R., & Liu, H.-M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00698-1 · Cited by 119 · see citing works

Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations

Yu, Z.-H., Zhang, R.-Y., Walls, C. D., Chen, L., Zhang, S., Wu, L., Liu, S., & Zhang, Z.-Y. (2014) · Biochemistry · doi:10.1021/bi5002695 · Cited by 87 · see citing works

6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors

Sarver, P., Acker, M., Bagdanoff, J. T., Chen, Z., Chen, Y.-N., Chan, H., Firestone, B., Fodor, M., Fortanet, J., Hao, H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01726 · Cited by 87 · see citing works

Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations

Oishi, K., Gaengel, K., Krishnamoorthy, S., Kamiya, K., Kim, I.-K., Ying, H., Weber, U., Perkins, L. A., Tartaglia, M., Mlodzik, M., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi471 · Cited by 81 · see citing works

Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors

Henel, G., Singh, K., Cui, D., Pryshchep, S., Lee, W.-W., Weyand, C. M., & Goronzy, J. J. (2006) · Blood · doi:10.1182/blood-2005-06-2519 · Cited by 61 · see citing works

The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling

Fiebelkow, J., Guendel, A., Guendel, B., Mehwald, N., Jetka, T., Komorowski, M., Waldherr, S., Schaper, F., & Dittrich, A. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00770-7 · Cited by 53 · see citing works

JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies

Kang, D., Wang, Y., Lin, Y., Ma, W. W., Morgensztern, D., Leventakos, K., Bi, C., Ding, Y., Xiong, J., Yan, M., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3691 · Cited by 17 · see citing works

The Role of C-terminal Tyrosine Phosphorylation in the Regulation of SHP-1 Explored via Expressed Protein Ligation

Zhang, Z., Shen, K., Lü, W., & Cole, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210028200 · Cited by 150 · see citing works

The SH2 Domain is Required for Stable Phosphorylation of p561ck at Tyrosine 505, the Negative Regulatory Site

Gervais, F. G., Chow, L. M. L., Lee, J. M., Branton, P. E., & Veillette, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7112-7121.1993 · Cited by 44 · see citing works

A Phosphorylation-Dependent Gating Mechanism Controls the SH2 Domain Interactions of the Shc Adaptor Protein

George, R., Schüller, A. C., Harris, R., & Ladbury, J. E. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.12.040 · Cited by 21 · see citing works

Protein-tyrosine Phosphatase 1D Modulates Its Own State of Tyrosine Phosphorylation

Stein-Gerlach, M., Kharitonenkov, A., Vogel, W. F., Ali, S., & Ullrich, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24635 · Cited by 47 · see citing works

Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.

Vogel, W. F., & Ullrich, A. (1996) · PubMed · Cited by 69 · see citing works